/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Neoscope

Topic

Latest Stories

Golden Armada
5.21.20, 2:12 PM EDT on neoscope
Scientists Disguise Cancer-Hunting Nanorobots as Blood Cells
Seek And Destroy
5.20.20, 12:47 PM EDT on neoscope
These Scientists Say Nanobots Could Kill Individual Cancer Cells
Up-Close Telehealth
5.20.20, 10:56 AM EDT on neoscope
Doctors Are Using Mixed Reality to Treat COVID-19 Patients
Masks Up Masks Down
5.19.20, 5:23 PM EDT on neoscope
Biologist Has Great Advice on COVID Infection Risks
Open Wide
5.19.20, 3:10 PM EDT on neoscope
Disturbing-Looking Face Mask Has "Pac-Man"-Style Mouth Hole
Bad News
Updated 5.19.20, 9:36 AM EDT on neoscope
Multiple Models Predict 110,000 US Coronavirus Deaths by June
Vax Happened
5.18.20, 4:19 PM EDT on neoscope
Don't Get Too Excited, But This COVID Vaccine Looks Promising
Let It Rip!
5.18.20, 3:55 PM EDT on neoscope
A Fidget Spinner-Inspired Test Can Diagnose UTIs in Under an Hour
Cocktail Bar
5.15.20, 5:00 PM EDT on neoscope
Pharma Company Claims to Find Part of COVID-Fighting Cocktail
There's Hope
5.15.20, 2:36 PM EDT on neoscope
Good News: Human Body Builds "Robust" Immune Response to COVID
More Bad News
5.15.20, 11:25 AM EDT on neoscope
Report: COVID Has Spread to the World's Largest Refugee Camp
Kidney Failure
5.15.20, 10:56 AM EDT on neoscope
Study: COVID Patients Suffering Acute Kidney Damage
  • Previous
  • 1
  • ...
  • 173
  • 174
  • 175
  • ...
  • 217
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.